wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24633710-0D1F305F-04B6-4D21-8F12-ABF527D2DE58
Q24633710-0D1F305F-04B6-4D21-8F12-ABF527D2DE58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-0D1F305F-04B6-4D21-8F12-ABF527D2DE58
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
P2860
Q24633710-0D1F305F-04B6-4D21-8F12-ABF527D2DE58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-0D1F305F-04B6-4D21-8F12-ABF527D2DE58
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
114b32941c4e838a06e57ff04c844d39d96c4860
P2860
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.